GSE86982 | GSM2317477 | Illumina HiSeq 2500 | Homo sapiens | 54Dp4_G09_smart-seq | cultured embryonic stem cells[DCX+][BG121099] | days in culture: 54; cre line: DCX+; differentiation#: BG121099; control: FALSE |
GSE86982 | GSM2317733 | Illumina HiSeq 2500 | Homo sapiens | 54Dn1SK_G08_smart-seq | cultured embryonic stem cells[DCX-][RM165051][viral_barcoded] | days in culture: 54; cre line: DCX-; differentiation#: RM165051; control: FALSE; viral barcoded: viral_barcoded |
GSE86982 | GSM2317989 | Illumina HiSeq 2500 | Homo sapiens | 54Dp5_G06_smart-seq | cultured embryonic stem cells[DCX+][RM165048] | days in culture: 54; cre line: DCX+; differentiation#: RM165048; control: FALSE |
GSE86982 | GSM2318245 | Illumina HiSeq 2500 | Homo sapiens | SK_2_F01_smart-seq | cultured embryonic stem cells[RM165095][viral_barcoded] | days in culture: 54; differentiation#: RM165095; control: FALSE; viral barcoded: viral_barcoded |
GSE52529 | GSM1269048 | Illumina HiSeq 2500 | Homo sapiens | Cell T0_CT_H05 | Human Skeletal Muscle Myoblasts (HSMM) | cell type: Human Skeletal Muscle Myoblasts (HSMM); hour post serum-switch: 0; debris: FALSE; control well: FALSE; cells in well: 1; library protocol: Single-cell |
GSE57872 | GSM1395689 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH29_A03 | glioblastoma [Neu] | patient id: MGH29; cell type: Glioblastoma; subtype: Neu |
GSE57872 | GSM1395945 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH31_F07 | glioblastoma [Neu] | patient id: MGH31; cell type: Glioblastoma; subtype: Neu |
GSE57872 | GSM1396201 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_CSC8_C11 | gliomasphere CSC8 | cell line: CSC8; cell type: Gliomasphere Cell Line |
GSE64016 | GSM1562529 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp3.220 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |
GSE64016 | GSM1562794 | Illumina HiSeq 2500 | Homo sapiens | G2_Exp1.015 | single H1-Fucci cell sorted from G2-M phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |